Quantifying effects of ligands on androgen receptor nuclear translocation, intranuclear dynamics, and solubility - PubMed (original) (raw)
. 2006 Jul 1;98(4):770-88.
doi: 10.1002/jcb.20593.
Affiliations
- PMID: 16440331
- DOI: 10.1002/jcb.20593
Quantifying effects of ligands on androgen receptor nuclear translocation, intranuclear dynamics, and solubility
Marco Marcelli et al. J Cell Biochem. 2006.
Abstract
Using manual and automated high throughput microscopy (HTM), ligand-dependent trafficking of green fluorescent protein-androgen receptor (GFP-AR) was analyzed in fixed and living cells to determine its spatial distribution, solubility, mobility, and co-activator interactions. Within minutes, addition of the agonist R1881 resulted translocation of GFP-AR from the cytoplasm to the nucleus, where it displayed a hyperspeckled pattern and extraction resistance in low expressing cells. AR antagonists (Casodex, hydroxyflutamide) also caused nuclear translocation, however, the antagonist-bound GFP-AR had a more diffuse nuclear distribution, distinct from the agonist-bound GFP-AR, and was completely soluble; overexpressed GFP-AR in treated cells was extraction resistant, independent of ligand type. To more dramatically show the different effects of ligand on AR distribution, we utilized an AR with a mutation in the DNA binding domain (ARC619Y) that forms distinct foci upon exposure to agonists but retains a diffuse nuclear distribution in the presence of antagonists. Live-cell imaging of this mutant demonstrated that cytoplasmic foci formation occurs immediately upon agonist but not antagonist addition. Fluorescence recovery after photobleaching (FRAP) revealed that agonist-bound GFP-AR exhibited reduced mobility relative to unliganded or antagonist-bound GFP-AR. Importantly, agonist-bound GFP-AR mobility was strongly affected by protein expression levels in transiently transfected cells, and displayed reduced mobility even in slightly overexpressing cells. Cyan fluorescent protein-AR (CFP-AR) and yellow fluorescent protein-CREB binding protein (YFP-CBP) in the presence of agonists and antagonists were used to demonstrate that CFP-AR specifically co-localizes with YFP-CBP in an agonist dependent manner. Dual FRAP experiments demonstrated that CBP mobility mirrored AR mobility only in the presence of agonist. HTM enabled simultaneous studies of the sub-cellular distribution of GFP-AR and ARC619Y in response to a range of concentrations of agonists and antagonists (ranging from 10(-12) to 10(-5)) in thousands of cells. These results further support the notion that ligand specific interactions rapidly affect receptor and co-factor organization, solubility, and molecular dynamics, and each can be aberrantly affected by mutation and overexpression.
2006 Wiley-Liss, Inc.
Similar articles
- Antiandrogens prevent stable DNA-binding of the androgen receptor.
Farla P, Hersmus R, Trapman J, Houtsmuller AB. Farla P, et al. J Cell Sci. 2005 Sep 15;118(Pt 18):4187-98. doi: 10.1242/jcs.02546. Epub 2005 Sep 1. J Cell Sci. 2005. PMID: 16141232 - Dynamics of intracellular movement and nucleocytoplasmic recycling of the ligand-activated androgen receptor in living cells.
Tyagi RK, Lavrovsky Y, Ahn SC, Song CS, Chatterjee B, Roy AK. Tyagi RK, et al. Mol Endocrinol. 2000 Aug;14(8):1162-74. doi: 10.1210/mend.14.8.0497. Mol Endocrinol. 2000. PMID: 10935541 - Differential modulation of androgen receptor transcriptional activity by the nuclear receptor co-repressor (N-CoR).
Berrevoets CA, Umar A, Trapman J, Brinkmann AO. Berrevoets CA, et al. Biochem J. 2004 May 1;379(Pt 3):731-8. doi: 10.1042/BJ20031456. Biochem J. 2004. PMID: 14744261 Free PMC article. - Intranuclear organization and function of the androgen receptor.
Black BE, Paschal BM. Black BE, et al. Trends Endocrinol Metab. 2004 Nov;15(9):411-7. doi: 10.1016/j.tem.2004.09.006. Trends Endocrinol Metab. 2004. PMID: 15519887 Review. - Nucleocytoplasmic shuttling revealed by FRAP and FLIP technologies.
Köster M, Frahm T, Hauser H. Köster M, et al. Curr Opin Biotechnol. 2005 Feb;16(1):28-34. doi: 10.1016/j.copbio.2004.11.002. Curr Opin Biotechnol. 2005. PMID: 15722012 Review.
Cited by
- Bisphenol A affects androgen receptor function via multiple mechanisms.
Teng C, Goodwin B, Shockley K, Xia M, Huang R, Norris J, Merrick BA, Jetten AM, Austin CP, Tice RR. Teng C, et al. Chem Biol Interact. 2013 May 25;203(3):556-64. doi: 10.1016/j.cbi.2013.03.013. Epub 2013 Apr 4. Chem Biol Interact. 2013. PMID: 23562765 Free PMC article. - A comparative analysis of standard microtiter plate reading versus imaging in cellular assays.
Bushway PJ, Mercola M, Price JH. Bushway PJ, et al. Assay Drug Dev Technol. 2008 Aug;6(4):557-67. doi: 10.1089/adt.2008.139. Assay Drug Dev Technol. 2008. PMID: 18795873 Free PMC article. - Antitumor effects of bladder cancer-specific adenovirus carrying E1A-androgen receptor in bladder cancer.
Zhai Z, Wang Z, Fu S, Lu J, Wang F, Li R, Zhang H, Li S, Hou Z, Wang H, Rodriguez R. Zhai Z, et al. Gene Ther. 2012 Nov;19(11):1065-74. doi: 10.1038/gt.2011.180. Epub 2012 Jan 5. Gene Ther. 2012. PMID: 22218302 Free PMC article. - A natural androgen receptor antagonist induces cellular senescence in prostate cancer cells.
Hessenkemper W, Roediger J, Bartsch S, Houtsmuller AB, van Royen ME, Petersen I, Grimm MO, Baniahmad A. Hessenkemper W, et al. Mol Endocrinol. 2014 Nov;28(11):1831-40. doi: 10.1210/me.2014-1170. Epub 2014 Sep 9. Mol Endocrinol. 2014. PMID: 25203674 Free PMC article. - Heterodimerization with different Jun proteins controls c-Fos intranuclear dynamics and distribution.
Malnou CE, Brockly F, Favard C, Moquet-Torcy G, Piechaczyk M, Jariel-Encontre I. Malnou CE, et al. J Biol Chem. 2010 Feb 26;285(9):6552-62. doi: 10.1074/jbc.M109.032680. Epub 2010 Jan 6. J Biol Chem. 2010. PMID: 20053986 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous